Good news: Methylphenidate for ADHD in epilepsy

Developmental Medicine and Child Neurology

Volumn 55, Issue 7, 2013, Pages 590-591

  Shalev, Ruth ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; CENTRAL STIMULANT AGENT;

ATTENTION DEFICIT DISORDER; DEPRESSION; DISEASES; DRUG EFFICACY; DRUG SAFETY; EPILEPSY; EPILEPTIC DISCHARGE; EPILEPTIC FOCUS; GENERALIZED EPILEPSY; HUMAN; NOTE; PRIORITY JOURNAL; SUICIDAL IDEATION; TREATMENT CONTRAINDICATION; FEMALE; MALE; SEIZURE;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; EPILEPSY; FEMALE; HUMANS; MALE; METHYLPHENIDATE; SEIZURES;

EID: 84881505921     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/dmcn.12111     Document Type: Note

References (6)

1. Santos K, Palmini A, Radziuk AL, et al. The impact of methylphenidate on seizure frequency and severity in children with ADHD and difficult-to-treat epilepsies. Dev Med Child Neurol 20113; doi: 10.1111/dmcn.12121
2. Russ SA, Larson K, Halfon N. A national profile of childhood epilepsy and seizure disorder. Pediatrics 2012; 129: 256-64.
3. Lin JJ, Mula M, Hermann BP. Uncovering the neurobehavioral comorbidities of epilepsy over the lifespan. Lancet 2012; 380: 1180-92.
4. Jackson DC, Irwin W, Dabbs K, et al. Ventricular enlargement in new-onset pediatric epilepsies. Epilepsia 2011; 52: 2225-32.
5. Pulsipher DT, Dabbs K, Tuchsherer V, et al. Thalamo-frontal neurodevelopment in new-onset pediatric idiopathic generalized epilepsy. Neurology 2011; 76: 28-33.
6. Xia S, Li X, Kimball AE, Kelly MS, Lesser I, Branch C. Thalamic shape and connectivity abnormalities in children with attention- deficit/hyperactivity disorder. Psychiatry Res 2012; 204: 161-7.